Immunodeficiency
📧 Sign up to get email alerts when something new happens for Immunodeficiency.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-06-16Clinical Trial Update: Efficacy, Pharmacokinetics, Safety, and Tolerability of IGSC 20% in Subjects With Primary Immunodeficiency [Phase 3]
Phase 3 trial evaluating efficacy, pharmacokinetics, safety, and tolerability of IGSC 20% in subjects with primary immunodeficiency.
-
CLINICAL_TRIALS trial_result · 2020-03-04Clinical Trial Update: Safety, Tolerability, Patient Satisfaction and Cost of 16.5% Subcutaneous Immunoglobulin (Cutaquig®) Treatment [Phase 4]
Phase 4 trial assessing safety, tolerability, patient satisfaction, and cost of 16.5% subcutaneous immunoglobulin (Cutaquig) for primary and…
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Safety and Tolerability of Higher Infusion Parameters of IgPro20 (Hizentra) in Subjects With Primary Immunodeficiency (PID) [Phase 4]
Phase 4 trial assessing safety and tolerability of higher infusion parameters of Hizentra (IgPro20) in patients with primary immunodeficienc…
-
CLINICAL_TRIALS trial_result · 2019-11-15Clinical Trial Update: Comparison of Multigam IV (5% vs. 10%) in Patients With an Immunodeficiency Secondary to a Hematological Disorder
A completed clinical trial comparing 5% vs 10% Multigam IV in patients with immunodeficiency due to a hematologic disorder; results posted i…
-
CLINICAL_TRIALS trial_result · 2019-10-04Clinical Trial Update: Safety and Pharmacokinetics of IGSC 20% in Subjects With Primary Immunodeficiency [Phase 3]
Phase 3 clinical trial update evaluating safety and pharmacokinetics of IGSC 20% in subjects with primary immunodeficiency. Results posted a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-06-25Clinical Trial Update: IgG Level in Primary Immunodeficiency Switching From Standard SCIG to Every Other Week HyQvia [Phase 4]
Phase 4 trial evaluating IgG level when switching from standard SCIG to every-other-week HyQvia in patients with primary immunodeficiency; c…
-
CLINICAL_TRIALS trial_result · 2019-04-09Clinical Trial Update: A Study to Compare Quality of Life and Satisfaction in Primary Immunodeficient Patients Treated With Subcutaneous Injections of Gammanorm® 165 mg/mL Administered With Two Different Delivery Devices: Injections Using Pump or Rapid Push [Phase 4]
Phase 4 trial comparing quality of life and satisfaction in primary immunodeficiency patients using Gammanorm 165 mg/mL delivered by two dev…
-
CLINICAL_TRIALS trial_result · 2018-09-05Clinical Trial Update: Gammanorm Quality of Life Study in Immunodeficient Patients Using Rapid Push or Pumps [Phase 4]
Phase 4 trial update on Gammanorm quality-of-life in immunodeficient patients using rapid push or pumps has completed.
-
CLINICAL_TRIALS trial_result · 2018-06-07Clinical Trial Update: Evolution of Interleukin 7, Fat Mass and Metabolic Profile Before and After Transplantation
Clinical trial examining Interleukin-7 and its effects on fat mass and metabolic profile before and after transplantation has completed.
-
CLINICAL_TRIALS trial_result · 2018-03-15Clinical Trial Update: Evaluation of the Efficacy of the Sequencing Method by Gene-panel [NA]
This clinical trial update reports completion of a study evaluating the efficacy of a gene-panel sequencing method for diagnosing primary im…
-
CLINICAL_TRIALS trial_result · 2017-11-30Clinical Trial Update: Pilot and Feasibility Study of Reduced-Intensity Hematopoietic Stem Cell Transplant for MonoMAC [Phase 2]
Phase 2 pilot/feasibility study evaluating reduced-intensity hematopoietic stem cell transplant for MonoMAC syndrome.
-
CLINICAL_TRIALS trial_result · 2017-11-30Clinical Trial Update: Susceptibility to Infections in Ataxia Telangiectasia [NA]
Clinical trial investigating susceptibility to infections in Ataxia Telangiectasia has completed.
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: The Benefit of 5% IVIG for Patients With Primary Immunodeficiency Disorders Who Experience Adverse Events on 10% IVIG Preparations
A completed clinical trial reports that using 5% intravenous immunoglobulin reduces adverse events for patients with primary immunodeficienc…
-
CLINICAL_TRIALS trial_result · 2017-11-08Clinical Trial Update: Donor Lymphocyte Infusion After Alternative Donor Transplantation [Phase 1, Phase 2]
A donor lymphocyte infusion study following alternative donor transplantation was conducted in immunodeficiency patients, with phase 1 and p…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Effects of Immunonutrition on Biomarkers in Traumatic Brain Injury [NA]
A completed clinical trial from the University of Malaya evaluated whether immunonutrition alters biomarkers in traumatic brain injury.
-
CLINICAL_TRIALS trial_result · 2017-02-13Clinical Trial Update: Immune Benefits of Consumption of Dairy Yogurt in Elderly [NA]
The completed trial evaluates whether regular dairy yogurt consumption enhances immune function in elderly individuals with immunodeficiency…
-
CLINICAL_TRIALS trial_result · 2017-02-13Clinical Trial Update: Effect of Fermented Maillard Reacted Whey Protein on Immune Function [NA]
A completed clinical trial from Yonsei University evaluated whether Fermented Maillard Reacted Whey Protein affects immune function. The sni…
-
CLINICAL_TRIALS trial_result · 2016-04-22Clinical Trial Update: Memory T-cell Infusion to Improve Immunity After TCR-alpha/Beta Depleted Hematopoietic Stem Cell Transplantation [Phase 1, Phase 2]
Clinical trial update on memory T-cell infusion after TCR-alpha/beta depleted hematopoietic stem cell transplantation, with Phase 1/2 status…
-
CLINICAL_TRIALS trial_result · 2016-03-23Clinical Trial Update: Resolution of Primary Immune Defect in 22q11.2 Deletion Syndrome
A completed clinical trial investigating the resolution of the primary immune defect in individuals with 22q11.2 deletion syndrome.
-
CLINICAL_TRIALS trial_result · 2016-03-14Clinical Trial Update: Peripheral Blood Stem Cells Obtained From Normal Volunteers for Studying Retroviral Vector Mediated Gene Transfer Into Primitive Hematopoietic Cells and Vector Mediated Transgene Expression in Mature Hematopoietic Lineages
A completed St. Jude trial examines peripheral blood stem cells from healthy volunteers to study retroviral vector–mediated gene transfer in…
-
CLINICAL_TRIALS trial_result · 2015-07-07Clinical Trial Update: Diagnostic Immunization With Rabies Vaccine in Patients With PID [Phase 4]
A Phase 4 clinical trial is evaluating diagnostic immunization with a rabies vaccine in patients with primary immunodeficiency; the current …
-
CLINICAL_TRIALS trial_result · 2015-05-12Clinical Trial Update: Epigenetic Markers of B-Cell Function in Low Birth Weight Infants
A completed trial examining epigenetic markers related to B-cell function in low birth weight infants and how early growth status may influe…
-
CLINICAL_TRIALS trial_result · 2015-04-06Clinical Trial Update: Pharmacokinetics and Safety of IVIG Nanogam 100 mg/ml [Phase 3]
A Phase 3 trial evaluating the pharmacokinetics and safety of Nanogam 100 mg/mL intravenous immunoglobulin has completed in patients with pr…
-
CLINICAL_TRIALS trial_result · 2015-01-28Clinical Trial Update: Pharmacokinetics, Safety, and Tolerability of Subcutaneous GAMUNEX-C in Pediatric Subjects With Primary Immunodeficiency [Phase 4]
Phase 4 clinical trial update evaluating pharmacokinetics, safety, and tolerability of subcutaneous GAMUNEX-C in pediatric patients with pri…
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency [Phase 4]
Phase 4 study evaluating the safety and effectiveness of Gammaplex in youths with primary immunodeficiency disorders, including Common Varia…